Posaconazole for the prophylaxis of invasive aspergillosis in acute myeloid leukemia: Is it still useful outside the clinical trial setting?

BACKGROUND: Posaconazole prophylaxis during remission induction chemotherapy not only decreases the incidence of invasive aspergillosis (IA) but also improves the overall survival rate among patients with acute myeloid leukemia (AML). However, it remains debatable whether this result applies to pati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ther Adv Hematol
Hauptverfasser: Chen, Tsung-Chih, Wang, Ren Ching, Lin, Yu-Hui, Chang, Kuang-Hsi, Hung, Li-Ya, Teng, Chieh-Lin Jerry
Format: Artigo
Sprache:Inglês
Veröffentlicht: SAGE Publications 2020
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7607783/
https://ncbi.nlm.nih.gov/pubmed/33194163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620720965846
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge